81
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

A Novel Nomogram to Predict Symptomatic Intracranial Hemorrhage in Ischemic Stroke Patients After Intravenous Thrombolysis

ORCID Icon, , &
Pages 993-1003 | Received 11 Sep 2023, Accepted 12 Nov 2023, Published online: 28 Nov 2023

References

  • Feigin VL, Stark BA, Johnson CO, et al. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol. 2021;20(10):795–820. doi:10.1016/S1474-4422(21)00252-0
  • Wu S, Wu B, Liu M, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol. 2019;18(4):394–405. doi:10.1016/S1474-4422(18)30500-3
  • Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2019;50:12.
  • Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317–1329. doi:10.1056/NEJMoa0804656
  • Saver JL. Hemorrhage after thrombolytic therapy for stroke. Stroke. 2007;38(8):2279–2283. doi:10.1161/STROKEAHA.107.487009
  • Strbian D, Engelter S, Michel P, et al. Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN Score. Ann Neurol. 2012;71(5):634–641. doi:10.1002/ana.23546
  • Mazya M, Egido JA, Ford GA, et al. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase. Stroke. 2012;43(6):1524–1531. doi:10.1161/STROKEAHA.111.644815
  • Menon BK, Saver JL, Prabhakaran S, et al. Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. Stroke. 2012;43(9):2293–2299. doi:10.1161/STROKEAHA.112.660415
  • Cucchiara B, Tanne D, Levine SR, Demchuk AM, Kasner S. A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke. J Stroke Cerebrovascular Dis. 2008;17(6):331–333. doi:10.1016/j.jstrokecerebrovasdis.2008.03.012
  • Saposnik G, Guzik AK, Reeves M, Ovbiagele B, Johnston SC. Stroke prognostication using age and NIH stroke scale: SPAN-100. Neurology. 2013;80(1):21–28. doi:10.1212/WNL.0b013e31827b1ace
  • Lou M, Safdar A, Mehdiratta M, et al. The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis. Neurology. 2008;71(18):1417–1423. doi:10.1212/01.wnl.0000330297.58334.dd
  • Wu Y, Chen H, Liu X, et al. A new nomogram for individualized prediction of the probability of hemorrhagic transformation after intravenous thrombolysis for ischemic stroke patients. BMC Neurol. 2020;20(1). doi:10.1186/s12883-020-02002-w
  • Yang M. A novel nomogram to predict hemorrhagic transformation in ischemic stroke patients after intravenous thrombolysis. Front Neurol. 2022;3:13.
  • Zhang K, Luan J, Li C, Chen M. Nomogram to predict hemorrhagic transformation for acute ischemic stroke in Western China: a retrospective analysis. BMC Neurol. 2022;22(1). doi:10.1186/s12883-022-02678-2
  • Zhang XX, Yao FR, Zhu JH, et al. Nomogram to predict haemorrhagic transformation after stroke thrombolysis: a combined brain imaging and clinical study. Clin Radiol. 2022;77(1):e92–e98. doi:10.1016/j.crad.2021.09.017
  • Shen Y, Xiong Y, Cao Q, et al. Construction and validation of a nomogram model to predict symptomatic intracranial hemorrhage after intravenous thrombolysis in severe white matter lesions. J Thromb Thrombol. 2023;56(1):111–120. doi:10.1007/s11239-023-02828-4
  • Guo H, Xu W, Zhang X, et al. A nomogram to predict symptomatic intracranial hemorrhage after intravenous thrombolysis in Chinese patients. Neuropsych Dis Treat. 2021;17:2183–2190. doi:10.2147/NDT.S320574
  • Weng Z-A, Huang X-X, Deng D, et al. A new nomogram for predicting the risk of intracranial hemorrhage in acute ischemic stroke patients after intravenous thrombolysis. Front Neurol. 2022;1:13.
  • Xie X, Yang J, Ren L, et al. Nomogram to predict symptomatic intracranial hemorrhage after intravenous thrombolysis in acute ischemic stroke in Asian Population. Curr Neurovasc Ees. 2021;18(5):543–551. doi:10.2174/1567202619666211223150907
  • Zhou Z, Yin X, Niu Q, Liang S, Mu C, Zhang Y. Risk factors and a nomogram for predicting intracranial hemorrhage in stroke patients undergoing thrombolysis. Neuropsych Dis Treat. 2020;16:1189–1197. doi:10.2147/NDT.S250648
  • Wardlaw JM, Mielke O. Early signs of brain infarction at CT: observer reliability and outcome after thrombolytic treatment--systematic review. Radiology. 2005;235(2):444–453. doi:10.1148/radiol.2352040262
  • Larrue V, von Kummer RR, Müller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke. 2001;32(2):438–441. doi:10.1161/01.STR.32.2.438
  • Keselman B, Gdovinová Z, Jatuzis D, et al. Safety and outcomes of intravenous thrombolysis in posterior versus anterior circulation stroke. Stroke. 2020;51(3):876–882. doi:10.1161/STROKEAHA.119.027071
  • Sarikaya H, Arnold M, Engelter ST, et al. Outcomes of intravenous thrombolysis in posterior versus anterior circulation stroke. Stroke. 2011;42(9):2498–2502. doi:10.1161/STROKEAHA.110.607614
  • Kasner SE. Clinical interpretation and use of stroke scales. Lancet Neurol. 2006;5(7):603–612. doi:10.1016/S1474-4422(06)70495-1
  • Singer OC, Humpich MC, Fiehler J, et al. Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging. Ann Neuro. 2008;63(1):52–60. doi:10.1002/ana.21222
  • Singer OC, Kurre W, Humpich MC, et al. Risk assessment of symptomatic intracerebral hemorrhage after thrombolysis using DWI-ASPECTS. Stroke. 2009;40(8):2743–2748. doi:10.1161/STROKEAHA.109.550111
  • Derex L. Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator. J Neurol Neurosurg Psychiatry. 2005;76(1):70–75. doi:10.1136/jnnp.2004.038158
  • Arakawa S, Wright PM, Koga M, et al. Ischemic thresholds for gray and white matter. Stroke. 2006;37(5):1211–1216. doi:10.1161/01.STR.0000217258.63925.6b
  • Bristow MS, Simon JE, Brown RA, et al. MR perfusion and diffusion in acute ischemic stroke: human gray and white matter have different thresholds for infarction. J Cerebral Blood Flow Metabol. 2005;25(10):1280–1287. doi:10.1038/sj.jcbfm.9600135
  • Chen C, Bivard A, Lin L, Levi CR, Spratt NJ, Parsons MW. Thresholds for infarction vary between gray matter and white matter in acute ischemic stroke: a CT perfusion study. J Cerebral Blood Flow Metabol. 2017;39(3):536–546. doi:10.1177/0271678X17744453
  • He L. Hyponatremia is associated with post-thrombolysis hemorrhagic transformation and poor clinical outcome in ischemic stroke patients. Front Mol Neurosci. 2022;4:15.
  • Krueger M, Bechmann I, Immig K, Reichenbach A, Härtig W, Michalski D. Blood—brain barrier breakdown involves four distinct stages of vascular damage in various models of experimental focal cerebral ischemia. J Cerebral Blood Flow Metabol. 2014;35(2):292–303. doi:10.1038/jcbfm.2014.199
  • Rocha EA, Topcuoglu MA, Singhal AB. Post-stroke recrudescence from infection: an immunologic mechanism? Translat Stroke Re. 2018;10(2):146–149. doi:10.1007/s12975-018-0651-x
  • Daneman R, Prat A. The blood–brain barrier. Cold Spring Harbor Perspect Biol. 2015;7(1):a020412. doi:10.1101/cshperspect.a020412
  • Khanna A, Kahle KT, Walcott BP, Gerzanich V, Simard JM. Disruption of Ion homeostasis in the neurogliovascular unit underlies the pathogenesis of ischemic cerebral edema. Translat Stroke Re. 2013;5(1):3–16. doi:10.1007/s12975-013-0307-9